Skip to main content

CORRECTION article

Front. Mol. Neurosci., 05 December 2022
Sec. Molecular Signalling and Pathways
Volume 15 - 2022 | https://doi.org/10.3389/fnmol.2022.1099324

Corrigendum: Potential therapeutic role of SIRT1 in age- related hearing loss

This article is a correction to:

  1. Potential therapeutic role of SIRT1 in age- related hearing loss

    1. Read original article
\nTingting Zhao,Tingting Zhao1,2Guangyong Tian, Guangyong Tian1,2*
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
  • 2Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Guangzhou, China

A corrigendum on
Potential therapeutic role of SIRT1 in age- related hearing loss

by Zhao, T., and Tian, G. (2022). Front. Mol. Neurosci. 15:984292. doi: 10.3389/fnmol.2022.984292

In the published article, there was an error in the article title. Instead of “STRT1,” it should be “SIRT1.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SIRT1, age-related hearing loss, ARHL, cochlea, hearing loss, age

Citation: Zhao T and Tian G (2022) Corrigendum: Potential therapeutic role of SIRT1 in age- related hearing loss. Front. Mol. Neurosci. 15:1099324. doi: 10.3389/fnmol.2022.1099324

Received: 15 November 2022; Accepted: 16 November 2022;
Published: 05 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhao and Tian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guangyong Tian, tian1970@smu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.